These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29121497)

  • 21. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
    Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
    Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
    Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
    AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
    Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
    J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor.
    Timpano G; Tabarani G; Anderluh M; Invernizzi D; Vasile F; Potenza D; Nieto PM; Rojo J; Fieschi F; Bernardi A
    Chembiochem; 2008 Aug; 9(12):1921-30. PubMed ID: 18655085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New branched amino acids for high affinity dendrimeric DC-SIGN ligands.
    Cattiaux L; Porkolab V; Fieschi F; Mallet JM
    Bioorg Med Chem; 2018 Mar; 26(5):1006-1015. PubMed ID: 29428526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.
    Dos Santos Á; Hadjivasiliou A; Ossa F; Lim NK; Turgut A; Taylor ME; Drickamer K
    Protein Sci; 2017 Feb; 26(2):306-316. PubMed ID: 27859859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-carbohydrate inhibitors of the lectin DC-SIGN.
    Borrok MJ; Kiessling LL
    J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.
    Serrano-Gómez D; Martínez-Nuñez RT; Sierra-Filardi E; Izquierdo N; Colmenares M; Pla J; Rivas L; Martinez-Picado J; Jimenez-Barbero J; Alonso-Lebrero JL; González S; Corbí AL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2313-23. PubMed ID: 17452477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.
    Bertolotti B; Sutkeviciute I; Ambrosini M; Ribeiro-Viana R; Rojo J; Fieschi F; Dvořáková H; Kašáková M; Parkan K; Hlaváčková M; Nováková K; Moravcová J
    Org Biomol Chem; 2017 May; 15(18):3995-4004. PubMed ID: 28443908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC-SIGN.
    Aretz J; Baukmann H; Shanina E; Hanske J; Wawrzinek R; Zapol'skii VA; Seeberger PH; Kaufmann DE; Rademacher C
    Angew Chem Int Ed Engl; 2017 Jun; 56(25):7292-7296. PubMed ID: 28523851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonhydrolyzable C-disaccharides, a new class of DC-SIGN ligands.
    Bertolotti B; Oroszová B; Sutkeviciute I; Kniežo L; Fieschi F; Parkan K; Lovyová Z; Kašáková M; Moravcová J
    Carbohydr Res; 2016 Nov; 435():7-18. PubMed ID: 27676269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
    Lozach PY; Amara A; Bartosch B; Virelizier JL; Arenzana-Seisdedos F; Cosset FL; Altmeyer R
    J Biol Chem; 2004 Jul; 279(31):32035-45. PubMed ID: 15166245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
    Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
    Hong PW; Nguyen S; Young S; Su SV; Lee B
    J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes.
    Di Gianvincenzo P; Chiodo F; Marradi M; Penadés S
    Methods Enzymol; 2012; 509():21-40. PubMed ID: 22568899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.
    Feinberg H; Mitchell DA; Drickamer K; Weis WI
    Science; 2001 Dec; 294(5549):2163-6. PubMed ID: 11739956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.